๋“ฑ์žฅ์„ฑ ๊ฒฐ์ •์งˆ ์ˆ˜์•ก / Isotonic crystalloid

์ •์˜

Isotonic crystalloid๋Š” hypovolemia ๋˜๋Š” prerenal AKI ๊ต์ •์— ์‚ฌ์šฉํ•˜๋Š” ๊ธฐ๋ณธ ์ •๋งฅ ์ˆ˜์•ก์ด๋‹ค. Raw ์ž๋ฃŒ์—์„œ๋Š” 0.9% normal saline ๋˜๋Š” balanced crystalloid๊ฐ€ ์˜ˆ์‹œ๋กœ ์ œ์‹œ๋œ๋‹ค.

์ž„์ƒ ํ•ต์‹ฌ

AKI on CKD์—์„œ isotonic crystalloid๋Š” volume depletion์ด ์˜์‹ฌ๋  ๋•Œ๋งŒ ์กฐ์‹ฌ์Šค๋Ÿฝ๊ฒŒ ์‚ฌ์šฉํ•œ๋‹ค. CKD, HF, ๊ณ ๋ น, ๋ถ€์ข… ์œ„ํ—˜๊ตฐ์—์„œ๋Š” ๊ณผ๋Ÿ‰ ํˆฌ์—ฌ๊ฐ€ pulmonary congestion๊ณผ fluid overload๋ฅผ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค. ๋ช…ํ™•ํ•œ shock/hypoperfusion์—์„œ๋Š” bolus๊ฐ€ ํ•„์š”ํ•  ์ˆ˜ ์žˆ์ง€๋งŒ, CKD/HF์—์„œ๋Š” ์ž‘์€ aliquot์œผ๋กœ ์žฌํ‰๊ฐ€ํ•˜๋Š” ๋ฐฉ์‹์ด ์•ˆ์ „ํ•˜๋‹ค.

์ง„๋‹จ

ํˆฌ์—ฌ ์ „ BP, HR, urine output, JVP, edema, lung sound, SpO2, lung US B-lines, IVC, CXR๋ฅผ ํ™•์ธํ•œ๋‹ค. ์ˆ˜์•ก ํ›„์—๋„ ๊ฐ™์€ ํ•ญ๋ชฉ์„ 2โ€“4์‹œ๊ฐ„๋งˆ๋‹ค ๋ฐ˜๋ณต ํ‰๊ฐ€ํ•œ๋‹ค.

์น˜๋ฃŒ

Shock ๋˜๋Š” hypoperfusion์—์„œ๋Š” 250โ€“500 mL์”ฉ bolus ํ›„ ์ฆ‰์‹œ ์žฌํ‰๊ฐ€ํ•œ๋‹ค. Hemodynamically stableํ•˜์ง€๋งŒ ํƒˆ์ˆ˜๊ฐ€ ์˜์‹ฌ๋˜๋ฉด 0.9% NS ๋˜๋Š” balanced crystalloid 60โ€“100 mL/hr๋กœ ์‹œ์ž‘ํ•  ์ˆ˜ ์žˆ๋‹ค. ๋…ธ์ธ, CKD, HF, edema risk๊ฐ€ ์žˆ์œผ๋ฉด 40โ€“60 mL/hr์ฒ˜๋Ÿผ ๋‚ฎ๊ฒŒ ์‹œ์ž‘ํ•œ๋‹ค. NICE ์ผ๋ฐ˜ maintenance๋Š” 25โ€“30 mL/kg/day์ด๋‚˜ renal impairment, cardiac failure, frailty์—์„œ๋Š” 20โ€“25 mL/kg/day ์ดํ•˜๋กœ ์ค„์ด๋ผ๊ณ  ๊ถŒ๊ณ ๋œ๋‹ค.

์ถœ์ฒ˜

KDIGO AKI; NICE IV fluids CG174.

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.